Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Common Share (Schedule of Diluted Weighted Average Shares Outstanding) (Details)

v3.23.3
Net Loss per Common Share (Schedule of Diluted Weighted Average Shares Outstanding) (Details) - shares
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding 1,531,443 1,555,985
Warrants to Purchase Common Stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding 127,296 268,699
Options to Purchase Common Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding 34,890 54,128
Unvested Restricted Stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding 1,369,105 1,229,750
Unvested Restricted Stock Units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive securities excluded from the computations of diluted weighted average shares outstanding 152 3,407